BioCentury | Apr 15, 2013
Company News

Microscience management update

Microscience Ltd., London, U.K. Business: Infectious diseases/AIDS Hired: Robert Feldman, Ph.D., as CSO; formerly senior lecturer, department of infectious diseases, Royal Postgraduate Medical School (London, U.K.) WIR Staff Infectious...
BioCentury | Apr 15, 2013
Company News

Microscience scientific advisory board update

Microscience Ltd. , London, U.K. Business: Infectious diseases/AIDS Appointed: David Holden, Ph.D., professor of molecular microbiology, department of infectious diseases, Royal Postgraduate Medical School (London, U.K.) WIR Staff Infectious...
BioCentury | Jul 16, 2012
Company News

Emergent BioSolutions, Prokarium deal

...the oral delivery strain of S. typhi used in Typhella, through its 2005 acquisition of Microscience Ltd....
BioCentury | Aug 23, 2010
Strategy

The future emerges

...Clinical setbacks and other obstacles have stymied Emergent's previous attempts to branch out. Emergent acquired Microscience Ltd....
BioCentury | May 31, 2010
Finance

Performance Counts

...Ltd. Vernalis plc (LSE:VER) $18.2 $27.7 Biology: ion channel targets in the peripheral nervous system Microscience Ltd....
BioCentury | Aug 21, 2006
Finance

Ebb & Flow

...ABI-0043, is being developed to treat Gram-positive pathogens. Bigger by microdosing Similarly, Emergent's acquisition of Microscience...
...the joint lead manager; and HSBC Securities (USA), which will be the co-manager. By acquiring Microscience...
BioCentury | May 22, 2006
Company News

Vectura, Unilever Ventures Ltd. drug delivery news

...by Rod Richards as CEO and John Staniforth as CSO. Richards was previously CEO of Microscience Ltd....
BioCentury | May 16, 2006
Company News

Vectura spins out PharmaKodex

...by Rod Richards as CEO and John Staniforth as CSO. Richards was previously CEO of Microscience...
BioCentury | Dec 19, 2005
Strategy

Heading Stateside

...retained two-thirds of the firm's Cambridge, U.K., R&D facility Microscience Gaithersburg, Md. Emergent BioSolutions acquired Microscience...
BioCentury | Dec 19, 2005
Strategy

Abgenix chronicles

...including cancer and autoimmune diseases, using XenoMouse and CRGN's genomics-based antigensU. 5/7/03 - Partners with Microscience...
Items per page:
1 - 10 of 74
BioCentury | Apr 15, 2013
Company News

Microscience management update

Microscience Ltd., London, U.K. Business: Infectious diseases/AIDS Hired: Robert Feldman, Ph.D., as CSO; formerly senior lecturer, department of infectious diseases, Royal Postgraduate Medical School (London, U.K.) WIR Staff Infectious...
BioCentury | Apr 15, 2013
Company News

Microscience scientific advisory board update

Microscience Ltd. , London, U.K. Business: Infectious diseases/AIDS Appointed: David Holden, Ph.D., professor of molecular microbiology, department of infectious diseases, Royal Postgraduate Medical School (London, U.K.) WIR Staff Infectious...
BioCentury | Jul 16, 2012
Company News

Emergent BioSolutions, Prokarium deal

...the oral delivery strain of S. typhi used in Typhella, through its 2005 acquisition of Microscience Ltd....
BioCentury | Aug 23, 2010
Strategy

The future emerges

...Clinical setbacks and other obstacles have stymied Emergent's previous attempts to branch out. Emergent acquired Microscience Ltd....
BioCentury | May 31, 2010
Finance

Performance Counts

...Ltd. Vernalis plc (LSE:VER) $18.2 $27.7 Biology: ion channel targets in the peripheral nervous system Microscience Ltd....
BioCentury | Aug 21, 2006
Finance

Ebb & Flow

...ABI-0043, is being developed to treat Gram-positive pathogens. Bigger by microdosing Similarly, Emergent's acquisition of Microscience...
...the joint lead manager; and HSBC Securities (USA), which will be the co-manager. By acquiring Microscience...
BioCentury | May 22, 2006
Company News

Vectura, Unilever Ventures Ltd. drug delivery news

...by Rod Richards as CEO and John Staniforth as CSO. Richards was previously CEO of Microscience Ltd....
BioCentury | May 16, 2006
Company News

Vectura spins out PharmaKodex

...by Rod Richards as CEO and John Staniforth as CSO. Richards was previously CEO of Microscience...
BioCentury | Dec 19, 2005
Strategy

Heading Stateside

...retained two-thirds of the firm's Cambridge, U.K., R&D facility Microscience Gaithersburg, Md. Emergent BioSolutions acquired Microscience...
BioCentury | Dec 19, 2005
Strategy

Abgenix chronicles

...including cancer and autoimmune diseases, using XenoMouse and CRGN's genomics-based antigensU. 5/7/03 - Partners with Microscience...
Items per page:
1 - 10 of 74